Navigation Links
Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011
Date:9/12/2011

LISBON, Portugal, Sept. 12, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced new analyses from the DURATION-3 and -4 trials demonstrating patients treated with the investigational medication BYDUREON™ (exenatide extended-release for injectable suspension) experienced significant improvements in select cardiovascular risk factors, in comparison to patients who received commonly prescribed diabetes treatments. The analyses showed that patients receiving BYDUREON for the treatment of type 2 diabetes experienced improvements in composite endpoints related to body weight, abnormal blood pressure and abnormal lipid levels. These findings will be presented at the 47th European Association for the Study of Diabetes Annual Meeting in Lisbon, Portugal.

"Patients with diabetes are at least twice as likely as people without the disease to have heart disease or a stroke. Having other chronic conditions including obesity, high blood pressure or high cholesterol further increases this risk," said James Malone, MD, global exenatide medical director, Lilly Diabetes. "These data underscore the need to consider not only glycemic control but also the important role played by other medical conditions that are common among patients with type 2 diabetes."

Study Results: Patients participating in the DURATION-3 study received BYDUREON or Lantus® (insulin glargine) in addition to metformin or metformin plus a sulfonylurea. Interim results from the study's ongoing extension found that patients receiving BYDUREON and completing 84 weeks of therapy:

  • Demonstrated statistically significant reduction in body weight (
    '/>"/>

  • SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
    2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
    3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
    4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
    5. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
    6. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
    7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
    8. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
    9. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
    10. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
    11. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... 2014  Zacks.com announces the list of stocks featured in ... discuss the latest news and events impacting stocks and the ... (NYSE: HPQ - Free Report ), IBM (NYSE: ... SB - Free Report ), GlaxoSmithKline plc (NYSE: GSK ... FI - Free Report ). Today, Zacks is ...
    (Date:8/21/2014)... N.Y. , Aug. 21, 2014  Henry Schein, Inc. ... health care products and services to office-based dental, animal health ... at two investor conferences in September: , September ... New York , NY at 12:50 p.m. ET , ... Conference in New York , NY at 1:25 ...
    (Date:8/21/2014)... FRANCISCO , Aug. 21, 2014 /PRNewswire/ ... Food and Drug Administration (FDA) has granted ... detect atrial fibrillation (AFib), the most common ... process (algorithm) instantly detects if patients are ... taken on the mobile phone based AliveCor® ...
    Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11Henry Schein To Present At Two Investor Conferences In September 2AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
    ... Aug. 25, 2011 DDS Lab, a national dental ... innovation with Fierce mouthguards. Available in over twenty-seven colors ... mouthguards meet the needs of any athlete, from gymnasts ... Foundation for Safety, an athlete is 60 times more ...
    ... SPRING, Md., Aug. 25, 2011 The U.S. Food and ... of acute attacks of a rare condition called hereditary angioedema ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... levels or the improper function of a protein called C1 ...
    Cached Medicine Technology:DDS Lab Launches Fierce™ Mouthguards 2FDA Approves Firazyr To Treat Acute Attacks of Hereditary Angioedema 2
    (Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... to be filed in U.S. courts on behalf ... due to their use of prescription low testosterone ... documents, a new claim was filed against Pfizer ... who allegedly suffered life-threatening heart issues due to ...
    (Date:8/22/2014)... 2014 (HealthDay News) -- An intensive effort to sterilize feral ... shelter in Florida and euthanized, a new study reveals. ... slow their intake into animal control," Dr. Julie Levy, a ... of Veterinary Medicine, said in a university news release. ... a big impact," she explained, "so we wanted to pick ...
    (Date:8/22/2014)... Renal artery stenting to open blockages in ... historically been excluded from modern clinical trials, according ... in Catheterization and Cardiovascular Interventions today ... (SCAI). , University Hospitals Case Medical Center,s Sahil ... Professor of Medicine, Case Western Reserve University School ...
    (Date:8/22/2014)... 2014 (HealthDay News) -- Counseling may do little to ... finds. Researchers analyzed 66 studies that included nearly ... at high risk for drinking problems. Participants in 49 ... in the rest of the studies attended group sessions ... A counseling technique called motivational interviewing was used in ...
    (Date:8/22/2014)... Ohio (PRWEB) August 22, 2014 A new, ... mood-food connection. The summit is no-cost and open to ... best kept secrets, practical tips and advice on how to ... lose or manage weight. Mindful eating is not a ... and stay motivated instead of an "eat this, don't eat ...
    Breaking Medicine News(10 mins):Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Neutering Project Curbed Feral Cat Population 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Counseling Does Little to Deter Youth Drinking, Review Finds 2Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2
    ... insist that we should feel healthy to actually live ... bypass surgery; the patient’s attitude helps in an early ... health survey just before coronary bypass operations and assessed ... Following surgery those who had a better perception of ...
    ... most common and perhaps the most dreadful kind of Dementia, ... last have the much awaited miracle cure round the corner. ... in reducing plaque formation in mice, which is characteristic of ... It has gone into human testing ,the first stages of ...
    ... research into transcendental meditation says it is possible to ... of heart disease including high blood pressure and fatty ... transcendental meditation, practiced for 20 minutes twice a day, ... fatty deposits in arteries and also plays a major ...
    ... sit up and take notice in health care apart from AIDS ... is enough to bolster people to sit up and listen. But ... the disease? Or should we use our gray cells and analyse ... that is written about and said about the dreaded disease? Especially ...
    ... HIV sero discordant but who would like to have a baby. ... negative and they are planning to have a child the problem ... transmitting the virus to the female partner and through her to ... sperm are washed free of virus before insemination into the female ...
    ... of Uganda – the deadly Ebola virus in its latest ... to Health Ministry officials in Kampala. More shocking is ... doctors & nurses. But what shocked the nation was ... doctor spearheading the fight against Ebola in Gulu. There ...
    Cached Medicine News:Health News:The Cancer Rumour mill working over time 2Health News:Sperm washing helps couples – Breakthrough in focu 2
    Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
    Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
    Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
    Kleinert-Kutz Single Skin Hook, Large...
    Medicine Products: